Compare ANDE & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANDE | BCRX |
|---|---|---|
| Founded | 1947 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | N/A | 1994 |
| Metric | ANDE | BCRX |
|---|---|---|
| Price | $68.85 | $6.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $65.00 | $20.82 |
| AVG Volume (30 Days) | 285.0K | ★ 4.3M |
| Earning Date | 02-17-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.16% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.13 | N/A |
| Revenue | ★ $11,595,817,000.00 | $599,816,000.00 |
| Revenue This Year | $6.52 | $40.21 |
| Revenue Next Year | $3.73 | $6.13 |
| P/E Ratio | $32.39 | ★ N/A |
| Revenue Growth | 2.19 | ★ 45.38 |
| 52 Week Low | $31.03 | $6.00 |
| 52 Week High | $70.06 | $11.31 |
| Indicator | ANDE | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 74.49 | 51.18 |
| Support Level | $67.30 | $6.26 |
| Resistance Level | $70.06 | $6.91 |
| Average True Range (ATR) | 1.83 | 0.26 |
| MACD | 0.29 | 0.06 |
| Stochastic Oscillator | 80.62 | 85.92 |
Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.